Viewing Study NCT01145456


Ignite Creation Date: 2025-12-24 @ 11:32 PM
Ignite Modification Date: 2026-05-27 @ 1:50 PM
Study NCT ID: NCT01145456
Status: COMPLETED
Last Update Posted: 2014-02-24
First Post: 2010-06-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Gamma-Secretase Inhibitor RO4929097 and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Adenocarcinoma of the Pancreas View
None Recurrent Pancreatic Cancer View
None Stage III Pancreatic Cancer View
None Stage IV Pancreatic Cancer View
None Unspecified Adult Solid Tumor, Protocol Specific View
Keywords: